AU2001292500A1 - 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain - Google Patents

1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Info

Publication number
AU2001292500A1
AU2001292500A1 AU2001292500A AU9250001A AU2001292500A1 AU 2001292500 A1 AU2001292500 A1 AU 2001292500A1 AU 2001292500 A AU2001292500 A AU 2001292500A AU 9250001 A AU9250001 A AU 9250001A AU 2001292500 A1 AU2001292500 A1 AU 2001292500A1
Authority
AU
Australia
Prior art keywords
tetrahydropyridazino
diones
quinoline
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292500A
Inventor
Vernon Alford
Thomas Bare
Christine Barlaam
Dean Gordon Brown
Carey Lynn Horchler
Frances Marie Mclaren
Megan Murphy
Gary Banks Steelman
Rebecca Ann Urbanek
Edward Vacek
Wenhua Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001292500A1 publication Critical patent/AU2001292500A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001292500A 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain Abandoned AU2001292500A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23675300P 2000-09-29 2000-09-29
US60236753 2000-09-29
PCT/SE2001/002126 WO2002026741A1 (en) 2000-09-29 2001-09-28 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN

Publications (1)

Publication Number Publication Date
AU2001292500A1 true AU2001292500A1 (en) 2002-04-08

Family

ID=22890806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292500A Abandoned AU2001292500A1 (en) 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Country Status (5)

Country Link
US (1) US6946463B2 (en)
EP (1) EP1325004A1 (en)
JP (1) JP2004509965A (en)
AU (1) AU2001292500A1 (en)
WO (1) WO2002026741A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004509964A (en) * 2000-09-29 2004-04-02 アストラゼネカ・アクチエボラーグ 7-chloro-4-hydroxy-2- (2-pyridylethyl) -1,2,5,10-tetrahydropyridazino [4,5-b] quinoline-1,10-dione and its use for treating pain use
EP3357904B1 (en) * 2007-05-29 2022-07-06 Precigen, Inc. Chiral diachylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
CN105384684B (en) * 2015-12-16 2018-02-13 辽宁工程技术大学 A kind of preparation method of the picoline of 2 cyano group 6

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
GB9507318D0 (en) * 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds
US20030153571A1 (en) * 1999-12-23 2003-08-14 Brown Dean Gordon Method and composition for the treatment of pain
AU2420101A (en) * 1999-12-23 2001-07-09 Astrazeneca Ab Method and composition for the treatment of pain
WO2001047925A1 (en) * 1999-12-23 2001-07-05 Astrazeneca Ab Compounds and methods for the treatment of pain
US20030162783A1 (en) * 1999-12-23 2003-08-28 Vernon Alford Method and composition for the treatment of pain
DE60026883T2 (en) 1999-12-23 2006-11-23 Astrazeneca Ab METHODS AND COMPOSITIONS FOR TREATING PAIN
WO2001047923A1 (en) * 1999-12-23 2001-07-05 Astrazeneca Ab Compounds and methods for the treatment of pain
JP2004509964A (en) * 2000-09-29 2004-04-02 アストラゼネカ・アクチエボラーグ 7-chloro-4-hydroxy-2- (2-pyridylethyl) -1,2,5,10-tetrahydropyridazino [4,5-b] quinoline-1,10-dione and its use for treating pain use

Also Published As

Publication number Publication date
US20040053929A1 (en) 2004-03-18
US6946463B2 (en) 2005-09-20
EP1325004A1 (en) 2003-07-09
WO2002026741A1 (en) 2002-04-04
JP2004509965A (en) 2004-04-02

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL187512A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU5788300A (en) Medical treatment method and kit
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2001257069A1 (en) Photostimulaton treatment apparatus and methods for use
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001235595A1 (en) 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
PL349364A1 (en) Use of pyridazino[4,5-b
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas